MAULDIN, SC / ACCESSWIRE / June 22, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it has initiated its plan to upgrade the trading of its common stock from the OTC Pink Market to the OTCQB Venture Market. The Company has submitted OTCQB application materials to OTC Markets Group, operator of OTCMarkets.com. The listing of the Company’s common shares on the OTCQB remains subject to the approval of the OTCQB.
The OTCQB is recognized by the Securities and Exchange Commission as an established public market providing public information for analysis and value of securities. As a verified market with efficient access for U.S. investors, OTCQB helps companies build shareholder value with the goal of enhancing liquidity and achieving a fair valuation.
“We believe that trading on the OTCQB will increase Xcelerates’ visibility to the investment community, including institutional investors, as we continue to develop a pilot program in Africa through our subsidiary, AfiyaSasa Africa, LLC. (‘ASA’), a medical technology and virtual health company and the development the portfolio of patents recently acquired from HS Pharmaceuticals as well as our continued development of patentable med-tech,” stated Michael O’Shea, CEO of Xcelerate.
For more information please visit www.xcelerate.global
SAFE HARBOR
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.
Xcelerate Contact:
Info@Xcelerate.Global
SOURCE: Xcelerate, Inc.
View source version on accesswire.com:
https://www.accesswire.com/706070/Xcelerate-Inc-Applies-to-Trade-on-the-OTCQB-Venture-Marketplace
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…